Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine PK and Efficacy in R/R PCNSL
NCT03392714Phase 2Unknown
- Sponsor
- Chonnam National University Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bendamustine in primary central nervous system lymphoma (PCNSL), sponsored by Chonnam National University Hospital. Primary endpoint: Overall Response Rate at 2 years. Status: unknown.
02
Drugs
bendamustine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT03392714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392714.